A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease-Reference-Cited by-同舟云学术

A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease

Published:1997-01-01 Issue:1 Volume:175 Page:16-25
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:Journal of Infectious Diseases

Author:

Boursnell M. E. G.,Entwisle C.,Blakeley D.,Roberts C.,Duncan I. A.,Chisholm S. E.,Martin G. M.,Jennings R.,Ni Challanain D.,Sobek I.,Inglis S. C.,McLean C. S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective efficacy against two different viral hemorrhagic septicemia virus (VHSV) isolates belonging to genotype IVa depending on various dose-boost immunizations of rVHSV-GΔTM in olive flounder;Aquaculture;2024-11

2. A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion;PLOS Pathogens;2024-09-03

3. Protective Efficacy Against Two Different Viral Hemorrhagic Septicemia Virus (Vhsv) Isolates Belonging to Genotype Iva Depending on Various Dose-Boost Immunizations of Rvhsv-Gδtm in Olive Flounder;2024

4. Prevention of fatal equine herpesvirus type 1 encephalitis in mice by immunization with a limited-replication cycle virus;Veterinary Microbiology;2023-02

5. An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections;Vaccines;2023-01-17